Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Feb 27, 2024; 16(2): 396-408
Published online Feb 27, 2024. doi: 10.4240/wjgs.v16.i2.396
Published online Feb 27, 2024. doi: 10.4240/wjgs.v16.i2.396
Table 2 Toxicity of neoadjuvant chemotherapy
| Feature | Grade 1/2, n = 120 (%) | Grade 3/4, n = 77 (%) | Total, n = 197 |
| Anemia | 107 (89.17) | 36 (46.75) | 143 (72.59) |
| Leukopenia | 33 (27.50) | 20 (25.97) | 53 (26.90) |
| Neutropenia | 25 (20.83) | 6 (7.79) | 31 (15.74) |
| Thrombocytopenia | 27 (22.50) | 17 (22.08) | 44 (22.34) |
| Nausea/vomiting | 57 (47.50) | 12 (15.58) | 69 (35.03) |
| Diarrhea | 12 (10.00) | 1 (1.30) | 13 (6.60) |
| Hepatic impairment | 21 (17.50) | 10 (13.00) | 31 (15.74) |
| Hand-foot syndrome | 39 (32.50) | 0 | 39 (19.80) |
| Cardiotoxicity | 1 (0.83) | 0 | 1 (0.51) |
- Citation: Liu B, Xu YJ, Chu FR, Sun G, Zhao GD, Wang SZ. Development of a clinical nomogram for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer. World J Gastrointest Surg 2024; 16(2): 396-408
- URL: https://www.wjgnet.com/1948-9366/full/v16/i2/396.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i2.396